Colorectal Cancer Trial, Recruiting NCT07333053 Sponsor: Quanda Liu Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07333053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed with colorectal cancer confirmed through a CT or MRI scan and a tissue sample taken during a colonoscopy
  • People whose cancer cannot be treated with surgery, either because of their overall health or because of where the tumor is located or how far it has spread
  • People who have not had chemotherapy before, or who have had chemotherapy previously but whose cancer still responds to it
  • People whose blood, heart, liver, and kidney function meet specific healthy ranges required by the trial (confirm with trial site for exact values)
  • People who are expected to live for at least 3 months
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have another type of cancer in addition to colorectal cancer
  • People who have a hole or tear in their gastrointestinal tract (gut perforation)
  • People who have a known allergy to the anti-cancer medicines used in this trial
  • Women who are pregnant, breastfeeding, or planning to become pregnant
  • People who are already receiving other cancer treatments at the same time, such as chemotherapy, targeted therapy, or radiation therapy
  • People whose colorectal cancer has a specific genetic characteristic known as MSI-H or dMMR (confirm with trial site)
  • People whom the treating doctor or trial investigator considers unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Quanda Liu, MD, Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Phone: 01088001037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Quanda Liu
Registry
ClinicalTrials.gov
Start date
31 March 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ORR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov